Gaining: pediatric patients and use of atypical antipsychotics.
Towbin
Kenneth E
KE
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001321:Autistic Disorder / Q000188:drug therapy / Q000523:psychology; D015992:Body Mass Index; D002648:Child; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D009765:Obesity / Q000139:chemically induced* / Q000517:prevention & control; D011618:Psychotic Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D015430:Weight Gain / Q000187:drug effects*
D014150:Antipsychotic Agents; D007004:Hypoglycemic Agents; D008687:Metformin